To,
The Members,
Your Directors are pleased to present the 34th Annual Report of your
company together with the audited financial statements (standalone and consolidated) of
the company for the financial year ended 31st March 2026.
1. FINANCIAL HIGHLIGHTS:
Financial results for the year under review and as well as previous
year are as follows.
(Rupees in Lakhs
Particulars |
Standalone |
Consolidated |
|
Year Ended 31.3.2026 |
Year Ended 31.3.2025 |
Year Ended 31.3.2026 |
Year Ended 31.3.2025 |
Revenue from Operations |
805.94 |
1217.80 |
1119.66 |
1562.44 |
Other income |
372.51 |
247.79 |
119.18 |
66.18 |
Total Income |
1178.46 |
1465.60 |
1238.84 |
1628.63 |
Total Expenditure |
3562.95 |
2788.70 |
4216.08 |
3551.27 |
Profit Before Tax (PBT) |
(3280.35) |
(1323.10) |
(2977.24) |
(1922.64) |
Exceptional item |
(895.85) |
- |
2399.75 |
- |
Tax Expense: |
|
|
|
|
a. current Tax |
720.55 |
|
720.55 |
|
b. Deferred Tax |
(31.40) |
(88.88) |
(26.03) |
(91.78) |
Profit After Tax (PAT) |
(3969.50) |
(1411.98) |
(1332.01) |
(2014.42) |
2. STATE OF COMPANY'S AFFAIR:
A comparative analysis at Consolidated Level and at Standalone Level,
year on year basis is hereunder:
At consolidated level, we have a total income of ' 1,238.84 lakhs for
the FY 2025-26 as against ' 1628.63 lakhs for the FY 2024-25. Similarly, we recorded a
Loss of ' 1,332.01 lakhs for FY 2025-26 as against a Loss of ' 2,014.42 lakhs for FY
2024-25.
At Standalone level, we have a total income of ' 1178.46 lakhs for the
FY 2025-26 as against ' 1465.60 lakhs for the FY 2024-25. Similarly, we recorded a Loss of
' (3969.50) lakhs for the FY 2025-26 as against a loss of ' 1,411.98 lakhs for the FY
2024-25.
3. DIVIDEND:
Due to inadequacy of profit, the directors of your Company do not
recommend any dividend for the financial year 2025-2026.
4. TRANSFER TO RESERVES:
The Company did not transfer any amount to the Reserves for the
Financial Year ended March 31,2026.
5. SHARE CAPITAL:
The Share Capital of the Company as on March 31,2026, stands as
follows:
Sl. No. Particulars |
(Amt. in ') |
| 1. Authorised Share Capital:
1,60,00,000 equity shares of ' 10/- each |
' 16,00,00,000 |
| 2 Issued, Subscribed & Paid-up
Capital:
1,47,11,588 Equity Shares of ' 10/- each |
' 14,71,15,880 |
Note: Details of Employee Stock Options
The Company has introduced the Athena Global Employees Stock Option
Scheme- 2019" .
The objective of the Scheme is to motivate the Employees to contribute
to the growth and profitability of the Company, retain the Employees and reduce the
attrition rate of the Company, achieve sustained growth and the creation of Shareholder
value by aligning the interests of the Employees with the long-term interests of the
company, create a sense of ownership and participation amongst the Employees to share the
value they create for the Company in the years to come and provide additional deferred
rewards to Employees.
The Scheme would result in grant of options not exceeding 5,00,000
equity shares of the Company. Each option, when exercised, would be converted into one
equity share of ' 60/- each (Rupees Sixty Only) fully paid up. The quantum of benefits
underlying the stock options issued to an eligible employee shall depend upon the number
of stock options held by the employee and the market price of the equity shares as on the
date of sale.
During the year under review the Company had granted 66,350 (Sixty-Six
Thousand Three Hundred and Fifty) stock options to its employees Athena Global Employees
Stock Option Scheme- 2019" after taking necessary approvals.
Following are the particulars of ESOP required to be disclosed as per
Rule 12(9) of Companies (Share Capital and Debentures) Rules, 2014: -
Details required to be disclosed |
Particulars |
| Description of the scheme |
Athena Global Employee Stock Option
Scheme-2019 |
| Date of shareholders' approval |
30-09-2019 |
| Total options approved |
5,00,000 Equity Shares |
| Options Granted during the year |
66,350 |
| Option Vested during the year |
37,838 |
| Option Exercised during the year |
11,588 |
| Option Lapsed during the year |
1,250 |
| The exercise price |
' 60/- |
| The total number of shares arising as a
result of exercise of option Variation of terms of Options |
11,588 |
| There is no variation of terms of options |
|
| Money realized by exercise of options |
6,95,280 |
Employee wise Details of Options Granted to (During FY 2025-26)
i) Key Managerial Personnel- Granted 1082 equity shares to Mr.
Julakanti Venkata Ramakrishna, CFO of the company.
ii) Any other employee who receives a grant of options in anyone year
of the Option amounting to 5% or more of Options granted during the year.-NA
iii) Identified employees who were granted Option, during any one year,
equal to or exceeding 1% of the issued capital (excluding warrants and conversions) of the
Company at the time of grant-NA
Further, information pursuant to Section 62 of the Companies Act, 2013
read with Rules made there under and details of the Scheme as specified in Part F of
Schedule - I of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
are available on Company's website and may be accessed at www.athenagt.com
Further, it is confirmed that the Scheme is in compliance with SEBI
(Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and during the year
under review there were no material changes in the Scheme.
Certificate from Mr. P S Rao and Associates, Practicing Company
Secretary, Secretarial Auditors of your Company confirming that the scheme has been
implemented in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity)
Regulations, 2021, forms part of the Corporate Governance Report and is also placed on the
website of your Company www.athenagt.com
6. MATERIAL CHANGES AND COMMITMENTS
Save as and except as discussed and stated in this Report, there are no
material changes and commitments affecting the financial position of your Company that
have occurred between the end of the Financial Year 2025-26 and the date of this report.
7. CHANGE IN THE NATURE OF THE BUSINESS :
During the Financial year under Review there is no change in the nature
of the Business.
8. FIXED DEPOSITS:
We have neither accepted nor repaid any deposits during the FY ended
31st March 2026. Further, there were no outstanding deposits as at the beginning of the FY
or at any time during the FY 2025-26. Hence, there are no details to be provided pursuant
to Rule 8 (5) (v) & (vi) of Companies (Accounts) Rules, 2014.
9. FUTURE OUTLOOK:
As we move forward into FY 2026-2027, Athena Global Technologies
remains committed to delivering sustainable growth through innovation, operational
excellence, and customer focused digital solutions. As the demand for digital
transformation continues to grow, the Company is well-positioned to capitalize on
opportunities in artificial intelligence, cloud computing, data analytics, cybersecurity,
and enterprise technology solutions. The Company will continue to strengthen its service
offerings, invest in emerging technologies, and expand its presence across domestic and
international markets. Athena also remains focused on developing a skilled and
future-ready workforce through continuous learning and talent development initiatives.
With a strong emphasis on corporate governance, financial discipline,
and customer satisfaction, the Company is confident in its ability to create long-term
value for shareholders and sustain profitable growth in the years ahead.
10. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTION
FUND:
Your Company did not have any funds lying unpaid or Unclaimed which
were required to be transferred to investors Education and Protection fund (IEPF) under
section 125 of Companies Act, 2013, as no dividend has been declared by the Company since
its inception.
11. MEETINGS:
During the year under review, Nine board meetings were held. The
maximum time gap between any two consecutive meetings was within the period prescribed
under Companies Act, 2013. The details of which are as follows.
S. No |
Dates of Board Meeting |
| 1 |
24-05-2025 |
| 2 |
10-07-2025 |
| 3 |
01-08-2025 |
| 4 |
11-08-2025 |
| 5 |
01-09-2025 |
| 6 |
14-11-2025 |
| 7 |
14-02-2026 |
| 8 |
24-02-2026 |
| 9 |
31-03-2026 |
12. SUBSIDIARIES
The subsidiary companies situated in India and outside India continue
to contribute to the business and overall performance of your Company. As of March
31,2026, your Company has the following subsidiaries:
a. Medleymed Healthcare Solutions Private Limited
b. Tutoroot Technologies private Limited (Wholly Owned Subsidiary)
c. Athena Global Technologies (UK) Limited
d. Athena Global Technologies, Inc.
13. PERFORMANCE AND CONTRIBUTION OF EACH OF THE SUBSIDIARIES
As per Rule 8 of Companies (Accounts) Rules, 2014, a report on the
financial performance of the subsidiary companies for the financial year ended March
31,2026, is summarized below
a. MedleyMed Healthcare Solutions Private Limited
MedleyMed Healthcare Solutions Private Limited is the Wholly Owned
Subsidiary Company of your company incorporated in the State of Telangana Hyderabad.
Operational performance of the Company, in brief is as hereunder:
(Amount in Lakhs)
Particulars |
FY- 2025-2026 |
FY-2025-2024 |
| Revenue from operations |
0 |
44.18 |
| Profit/ (Loss) for the year (before Interest,
Depreciation & Tax) |
(3.17) |
0.97 |
| Less: |
|
|
| Interest |
- |
- |
| Depreciation |
0.15 |
2.46 |
| Provision for Taxation |
|
|
| Net Profit/(Loss) |
(3.32) |
1.36 |
b. Tutoroot Technologies Private Limited
Tutoroot Technologies Private Limited is the Wholly Owned Subsidiary
Company of your company incorporated in the State of Telangana Hyderabad. Operational
performance of the Company, in brief is as hereunder. (Amount in
Lakhs)
Particulars |
FY- 2025-2026 |
FY-2025-2024 |
| Revenue from operations |
237.30 |
213.07 |
| Profit / (Loss) for the year (before
Interest, Depreciation & Tax) |
(101.82) |
1.21 |
| Less: |
|
|
| Interest |
- |
- |
| Depreciation |
25.70 |
17.52 |
| Provision for Taxation |
- |
- |
| Net Profit/ (Loss) |
(99.21) |
4.38 |
c. Athena Global Technologies, Inc.
Particulars |
FY- 2025-2026 |
FY-2024-2025 |
| Revenue from operations |
481.45 |
P785.04 |
| Profit/( Loss) for the year (before Interest,
Depreciation & Tax) |
(160.26) |
(279.77) |
| Less: |
|
|
| Interest |
11.76 |
NIL |
| Depreciation |
NIL |
NIL |
| Provision for Taxation |
NIL |
NIL |
| Net Profit/ (Loss) |
(172.02) |
(279.77) |
d. Athena Global Technologies UK- Business is yet to commence
Pursuant to the resolution passed by the Board of Directors at its
meeting held on 31st March, 2026, the Company divested its entire shareholding in Medley
Medical Solutions Private Limited in favour of MedleyMed Healthcare Solutions Private
Limited, consequent to which Medley Medical Solutions Private Limited ceased to be a
subsidiary of the Company with effect from that date. Simultaneously, the Company acquired
100% of the equity share capital of MedleyMed Healthcare Solutions Private Limited, which
thereby became a direct subsidiary of the Company with effect from 31st March, 2026, in
place of its earlier status as a step-down subsidiary. As the said acquisition took effect
only on the last day of the financial year, no separate financial performance of MedleyMed
Healthcare Solutions Private Limited as a direct subsidiary of the Company is reported for
FY 2025-26.
DETAILS OF SUBSIDIARY, JOINT VENTURE, OR ASSOCIATE COMPANIES
SUBSIDIARIES
The statement containing the salient features of the financial
statement of subsidiaries as per sub-section (3) of Section 129 of the Act in Form AOC-1
is annexed as Annexure I to this report.
15. Consolidated Financial Statements
The Consolidated Financial Statements are prepared in accordance with
Indian Accounting Standards (Ind AS) as per the Companies (Indian Accounting Standards)
Rules, 2015 notified under Section 133 of the Companies Act, 2013 and other relevant
provisions of the Act.
The Consolidated Financial Statements for the financial year ended
March 31,2026, form part of the Annual Report.
Further, we undertake that the annual accounts of the subsidiary
companies and the related detailed information will be made available to the shareholders
seeking such information at any point of time. Further, the annual accounts of the
subsidiary companies shall also be kept open for inspection by any shareholder at our
Registered office and that of the respective subsidiary Company.
Further, pursuant to the provisions of Section 136 of the Act, the
financial statements of your Company, consolidated financial statements along with
relevant documents and separate audited financial statements in respect of subsidiaries,
are available on the website of your Company at www.athenagt.com.
The policy for determining material subsidiaries is available on the
website of your Company which may be accessed at https://athenagt.com/investors
16. COMPANIES WHICH HAVE BECOME OR CEASED TO BE THE SUBSIDIARIES, JOINT
VENTURES OR ASSOCIATE COMPANIES DURING THE YEAR:
The Company does not have any associate or joint venture Company
falling within the definition under the Companies Act, 2013. During the year under review,
the Board of Directors at its meeting held on 31st March, 2026, approved the disinvestment
of the Company's entire shareholding in Medley Medical Solutions Private Limited, pursuant
to which the said company ceased to be a subsidiary of the Company with effect from 31st
March, 2026.
Further, the Company acquired 100% equity shareholding in MedleyMed
Healthcare Solutions Private Limited, pursuant to which the said company became a direct
subsidiary of the Company with effect from 31st March, 2026.
Both the aforesaid transactions, being between the Company and its
subsidiary, constitute related party transactions and were approved by the Board on an
arm's length basis and in the ordinary course of business, in compliance with the
applicable provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015. Save as aforesaid, there was no other instance
of any existing subsidiary of the Company ceasing to be as such, or any company becoming
its subsidiary, during the year under review.
17. CORPORATE SOCIAL RESPONSIBILITY
Since our Company does not fall within any of the parameters specified
under the provisions of Section 135 of the Companies Act, 2013 read with Rules made
thereunder, reporting pursuant to Section 134(3) (o) is Not Applicable.
18. LISTING OF EQUITY SHARES:
Your Company's equity shares are listed on BSE Limited, Phiroze
JeeJeebhoy Towers, Dalal Street, Mumbai- 400001, Maharashtra, India. It is traded with the
code 517429
Your Company has paid the Annual Listing Fees to the said Stock
Exchange for the Financial Year 2025-26.
19. INTERNAL FINANCIAL CONTROL SYSTEMS AND THEIR ADEQUACY:
Your Company has in place an Internal Control System, commensurate with
the size, scale and complexity of its operations. During the year, such controls were
tested and no reportable material weaknesses in the design or operation were observed.
Your Company has established and maintained a framework of internal financial controls and
compliance systems. Based on the framework of internal financial controls and compliance
systems established and maintained by the Company, the work performed by the internal,
statutory and secretarial auditors and external consultants, including the audit of
internal financial controls over financial reporting by the statutory auditors and the
reviews performed by management and the relevant board committees, including the audit
committee, the Board is of the opinion that the Company's internal financial controls were
adequate and your Company is constantly endeavouring to improve the standards of internal
control in various areas and taking steps to strengthen the internal control system to
make it commensurate and effective with the nature of its business.
Internal audit is carried on a quarterly basis. Internal auditors work
with all levels of management and the report is placed before the audit committee. The
audit committee after reviewing the findings and suggestions directs the respective
departments to implement the same.
20. STATUTORY AUDITORS AND AUDITORS REPORT:
M/s. Ramanatham & Rao, Chartered Accountants (FRN: 2934S) appointed
as the Statutory Auditors of your Company at the 30th Annual General Meeting held on
September 30, 2022, for a period of 5 years shall hold their office till the conclusion of
35th Annual General Meeting. The Statutory Auditors have confirmed their independence and
that they are not disqualified from continuing as Auditors of your Company.
The standalone and the consolidated financial statements of your
Company have been prepared in accordance with Ind AS notified under Section 133 of the
Act. The Statutory Auditors' reports do not contain any qualifications, reservations,
adverse remarks, matters of emphasis or disclaimers.
The Statutory Auditors were present in the last AGM held on September
30, 2025.
21. INTERNAL AUDITORS:
The Board of Directors, based on the recommendations of the Audit
Committee has appointed M/s Sarda & Agarwal., Chartered Accountants, Hyderabad, as the
Internal Auditor of the Company. The Internal Auditor submit their Report on quarterly
basis and the same is placed in the respective Meetings of the Audit Committee and that of
the Board of Directors.
22. COST RECORDS AND COST AUDIT:
Maintenance of cost records and requirement of cost audit as prescribed
under the provisions of Section 148(1) of the Act is not applicable for the business
activities carried out by the Company.
23. SECRETARIAL AUDITORS
Pursuant to the provisions of Section 204 of the Act and The Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, further, in view of
the amendments to Regulation 24A of the Listing Regulations your Company appointed M/s. P
S Rao & Associates, Company Secretaries (Peer Review Number: 6678/2025) to undertake
the Secretarial Audit of your Company from the FY 2025-26 to FY 2029-30 to undertake
Secretarial Audit for each of the said years. The Secretarial Audit Report issued by M/s.
FIS. Rao & Associates for the FY 2025-26 is enclosed as Annexure IX to this Report.
Further, we would like to clarify that the said Secretarial Audit Report does not contain
any observations or qualifications or reservations or adverse remarks or disclaimers.
In accordance with the provisions of Regulation 24A of the Listing
Regulations, Secretarial Audit of material unlisted Indian subsidiaries of the Company
namely, Tutoroot Technologies Private limited were undertaken by P S Rao & Associates,
Practicing Company Secretaries, Hyderabad and the Secretarial Audit Reports issued by them
to the Board of Tutoroot are provided as 'Annexure IX(A) to this Report. The
Secretarial Audit Reports for this material unlisted Indian subsidiaries do not contain
any qualification, reservation or adverse remark.
24. REPORTING OF FRAUDS
During the year under review, there was no instance of fraud,
misappropriation which required the Auditors to report to the Audit Committee and/or Board
under Section 143(12) of the Companies Act, 2013 and the rules made thereunder.
25. COMPLIANCE WITH SECRETARIAL STANDARDS
Your Company has devised proper systems to ensure compliance with the
provisions of all applicable Secretarial Standards issued by the Institute of Company
Secretaries of India and that such systems are adequate and are operating effectively.
During the year under review, your Company has complied with the Secretarial Standards
issued by the Institute of Company Secretaries of India.
26. PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS
Details of Loans, Guarantees and Investments made during the Financial
Year and / or outstanding as on March 31, 2026, covered under the provisions of Section
186 of the Act read with Companies (Meetings of Board and its Powers) Rules, 2014, are
provided in the notes to the Financial Statements.
27. DIRECTORS' RESPONSIBILITY STATEMENT
Pursuant to Section 134 (5) of the Act your Directors confirm that to
the best of their knowledge and belief and according to the information and explanation
obtained by them,
i) In the preparation of the annual accounts, the applicable accounting
standards have been followed along with proper explanation relating to material
departures;
ii) Such accounting policies as mentioned in the notes to the financial
statements have been selected and applied consistently and judgements and estimates that
are reasonable and prudent made so as to give a true and fair view of the state of affairs
of your Company at the end of the financial year 2025-26 and of the profit or loss of your
Company for that period;
iii) Proper and sufficient care has been taken for the maintenance of
adequate accounting records in accordance with the provisions of the Companies Act, 2013
for safeguarding the assets of your company and for preventing and detecting fraud and
other irregularities;
iv) The annual accounts for the year 2025-26 have been prepared on a
going concern basis.
v) That proper internal financial controls were in place and that the
financial controls were adequate and were operating effectively.
vi) That systems to ensure compliance with the provisions of all
applicable laws were in place and were adequate and operating effectively.
28. VIGIL MECHANISM / WHISTLE BLOWER POLICY
The Vigil Mechanism as envisaged in the Act, the Rules prescribed
thereunder and the Listing Regulations is implemented through your Company's Whistle
Blower Policy, to deal with instance of fraud and mismanagement, if any in the Group. The
Policy provides for adequate safeguards against victimization of employees who avail the
mechanism and also provides for direct access to the Chairman of the Audit Committee. The
details of the Policy are explained in the Corporate Governance Report and also posted on
the website of your Company and the web link https://athenagt.com/investors
The Whistle Blower Policy aims to conduct the affairs in a fair and
transparent manner by adopting highest standards of professionalism, honesty, integrity
and ethical behavior. All the employees of your Company are covered under the Whistle
Blower Policy.
29. RISK MANAGEMENT
We have a Risk Management Department in place whose primary role is to
identify potential risks, develop compatible Risk Management Systems and framework or
modify the existing ones to make the same adaptable and to mitigate the risk
appropriately.
We have been following the principle of risk minimization vis a vis our
business needs and the industry norms. The Department has been entrusted with the
responsibility to assist the Board in (a) overseeing and approving the Company's
enterprise-wide risk management framework and (b) overseeing that all the risks that the
organization faces such as financial, liquidity, security, property, IT, legal,
regulatory, reputational and other risks have been identified and assessed and ensuring
that there is an adequate risk management mechanism in place capable of addressing those
risks. Our Risk Management Policy may be accessed at: https://athenagt.com/investors
30. RELATED PARTY TRANSACTIONS AND PARTICULARS OF CONTRACTS OR
ARRANGEMENTS WITH RELATED PARTIES
All related party transactions that were entered into during the
financial year were on an arm's length basis and were in the ordinary course of business.
There are no materially significant related party transactions made by your Company with
Promoters, Directors, Key Managerial Personnel or other related parties which may have a
potential conflict with the interest of your Company at large.
During the year under review, the Board of Directors at its meeting
held on 31st March, 2026, approved the disinvestment of the Company's entire shareholding
in Medley Medical Solutions Private Limited, pursuant to which the said company ceased to
be a subsidiary of the Company with effect from 31st March, 2026.
Further, the Company acquired 100% equity shareholding in MedleyMed
Healthcare Solutions Private Limited, pursuant to which the said company became a direct
subsidiary of the Company with effect from 31st March, 2026. Both transactions, being
related party transactions, were approved by the Board on an arm's length basis and in the
ordinary course of business, in compliance with the applicable provisions of the Act and
the Listing Regulations, and further details thereof are provided in Annexure II in Form
AOC-2 to this report.
All related party transactions are placed before the Audit Committee
and also before the Board for approval. Prior omnibus approval of the Audit Committee is
obtained as per the Act and the Listing Regulations for the transactions which are
foreseeable and repetitive in nature.
Your Company has developed a Policy on Related Party Transactions for
the purpose of identification and monitoring of such transactions. Particulars of
contracts or arrangements with related parties are provided in Annexure II in Form AOC-2
pursuant to section 134(3)(h) of the Act read with rule 8(2) of the Companies (Accounts)
Rules, 2014 and forms part of this report.
The policy on materiality of Related Party Transactions and dealings in
related party transactions, as approved by the Board is uploaded on the website of your
Company and the web link is https://athenagt.com/investors
Disclosures of related party transactions under Regulation 34(3) read
with Schedule V of the Listing Regulations
Rs(in Lakhs)
S.No. In the accounts of |
Particulars |
Amount at the year ended 31st
March, 2026 |
Maximum amount outstanding during the
year 2025-26 |
| 1 Athena Global Technologies Limited |
(i) Loans and Advances to subsidiaries |
3986.99 |
3995.82 |
|
(ii) Loans and Advances to Joint Ventures
/ associates |
NA |
NA |
|
(iii) Loans and advances to firms/
companies in which Directors are interested |
NA |
NA |
| 2 Athena Global Technologies Limited |
Investment by the Loanee in the shares of
parent company / subsidiary company when the company has made a loan or advance |
NA |
NA |
31. PROHIBITION OF INSIDER TRADING:
In compliance with the provisions of Securities and Exchange Board of
India (Prohibition of Insider Trading) Regulations, 2015 (as amended from time to time)
and to preserve the confidentiality and prevent misuse of unpublished price sensitive
information, the Company has adopted a Code of Conduct for regulating, monitoring and
reporting of trading by Designated persons and their immediate relatives. This Code also
provides for periodical disclosures from the designated Persons and their immediate
Relatives as well as pre-clearance of transactions by such persons as per the thresholds
mentioned in the code
The code is applicable to Designated Persons and their Immediate
relatives who are likely or may reasonably be expected to have access to the unpublished
price sensitive information relating to the Company and the same is being implemented as a
self-regulatory mechanism.
32. GENDER-WISE COMPOSITION OF EMPLOYEES
In alignment with the principles of diversity, equity, and inclusion
(DEI), the Company discloses below the gender composition of its workforce as on the March
31,2026.
Male Employees: 55
Female Employees: 14
Transgender Employees: NIL
This disclosure reinforces the Company's efforts to promote an
inclusive workplace culture and equal opportunity for all individuals, regardless of
gender.
33. DETAILS OF EMPLOYEE STOCK OPTIONS:
Share based employee benefits are an effective mode aimed at promoting
the culture of employee ownership, creating long term wealth in their hands which also
helps your Company to attract, motivate and retain the employees in the competitive
environment and to reduce the employee retention rate in the organization.
With the said objective, and as already informed, your Company, has
adopted a Scheme under the name and style "Athena Global Employee Stock Option
Scheme-2019" (the Scheme) for the benefit of its employees. The said Scheme is in
force.
Further, Information pursuant to Section 62 of the Companies Act, 2013
read with Rules made thereunder and details of the Scheme as specified in Part F of
Schedule - I of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
are available on Company's website and may be accessed at https://athenagt.com
It is confirmed that the Scheme is in compliance with the SEBI (Share
Based Employee Benefits and Sweat Equity) Regulations, 2021 and during the year under
review no material changes were made to the Scheme.
Certificate has been obtained from M/s. FIS. Rao & Associates,
Company Secretaries, confirming that the Scheme has been implemented in accordance with
the SEBI Regulations and it will be placed at the forthcoming Annual General Meeting of
your Company for inspection by the members.
34. ANNUAL RETURN
In accordance with Section 134 (3) (a) of the Act a copy of Annual
Return in the prescribed format i.e., Form MGT-7 will be available on the website of your
Company at the link: : https://athenagt.com/investors
35. Management Discussion & Analysis
Pursuant to the provisions of Regulation 34(2) of the Listing
Regulations, a report on Management Discussion & Analysis is herewith annexed as
Annexure V to this report.
36. DIRECTORS & KEY MANAGERIAL PERSONNEL
The Board of Directors as on March 31, 2026 consists of Six (6)
directors, three (3) of whom are Independent Directors, remaining two (2) are
Non-Executive Directors and the balance one (1) is a Executive Director.
In accordance with the provisions of Companies Act, 2013 and the
Articles of Association of the Company, Mrs. M. Sunitha (DIN: 01843557), Director, retires
by rotation at the ensuing Annual General Meeting and, being eligible, offers herself for
reappointment. The Board recommends her re-appointment for the approval of the members.
Moreover, the Directors have devised proper systems and processes for
complying with the requirements of applicable Secretarial Standards issued by the
Institute of Company Secretaries of India and that such systems were adequate and
operating effectively.
CHANGE IN THE DIRECTORS AND KEY MANAGERIAL PERSONNEL:
The Company has a professional Board with Executive Directors &
Non-Executive Directors who bring the right mix of knowledge, skills, and expertise and
help the Company in implementing the best Corporate Governance practices.
During the year under review, the following changes took place in the
Directors and Key Managerial Personnel of the Company:
(i) Mr. Nukala Ashwanth (DIN: 09719259) vacated the office of
Independent Director of the Company with effect from 1st September, 2025, upon completion
of his two consecutive terms as permitted under Section 149(11) of the Act and Regulation
25(2) of the Listing Regulations. The Board places on record its appreciation for the
valuable contribution made by Mr. Nukala Ashwanth during his tenure as an Independent
Director.
(ii) Mr. Rajesh Katragadda (DIN: 02727491) was appointed as an
Additional Director in the capacity of an Independent Director of the Company with effect
from 1st September, 2025, pursuant to Section 161(1) read with Section 149 of the
Companies Act, 2013. The members of the Company approved his appointment as an Independent
Director at the Annual General Meeting held on 30th September, 2025, for the prescribed
term, and he is not liable to retire by rotation.
(iii) Ms. Gayathri Prithviraj (Membership No. A77113) was appointed as
the Company Secretary and Compliance Officer of the Company with effect from 01st August,
2025, pursuant to Section 203 of the Act read with Rule 8A of the Companies (Appointment
and Remuneration of Managerial Personnel) Rules, 2014, and Regulation 6(1) of the Listing
Regulations, in place of Ms. Divya Agrawal who had resigned with effect from 16th June,
2025.
Except as stated above, there was no other change in the Directors and
Key Managerial Personnel of the Company during the year under review and up to the date of
this report.
KEY MANAGERIAL PERSONNEL (KMP)
In terms of Section 203 of the Act, the following are the Key
Managerial Personnel of the Company as on March 31,2026:
| Mr. Satendra Manchala |
Managing Director |
| Mr. Venkata Rama Krishna Julakanti |
Chief Financial Officer |
| Ms. Divya Agrawal |
Company Secretary & Compliance Officer |
| * Resigned w.e.f June 16,2025 |
|
| Ms. Gayathri Prithviraj** |
|
| ** Appointed w.e.f August 01,2025 |
Company Secretary & Compliance Officer |
37. DECLARATION BY INDEPENDENT DIRECTORS
All Independent Directors of the Company have given declarations under
Section 149(7) of the Act, that they meet the criteria of independence as laid down under
Section 149(6) of the Act and Regulation 16(1)(b) of the Listing Regulations. In terms of
Regulation 25(8) of the Listing Regulations the Independent Directors have confirmed that
they are not aware of any circumstance or situation, which exists or may be reasonably
anticipated, that could impair or impact their ability to discharge their duties with an
objective, independent judgement and without any external influence.
In terms of Section 150 of the Act read with Rule 6 of the Companies
(Appointment and Qualification of Directors) Rules, 2014, as amended, all the Independent
Directors have got their names included in the data bank of Independent Directors
maintained with the Indian Institute of Corporate Affairs.
In the opinion of the Board, the Independent Directors possess the
requisite expertise and experience (including proficiency) and are persons of high
integrity and repute. They fulfil the conditions specified in the Act as well as the Rules
made thereunder and are independent of the Management.
38. COMPOSITION OF BOARD COMMITTEES
The Board has constituted the following committees, in accordance with
the provisions of the Act and the Listing Regulations as applicable, which are in place
and are discharging their functions as per terms of reference entrusted by the Board:
Audit Committee
Nomination and Remuneration Committee
Stakeholders Relationship Committee
The composition, attendance, powers and role of the Committees are
included in the Corporate Governance Report which forms part of this Annual Report.
39. POLICY ON DIRECTOR'S APPOINTMENT AND REMUNERATION AND OTHER MATTERS
a) Procedure for Nomination and Appointment of Directors:
The Nomination and Remuneration Committee has been formed in compliance
with Regulation 19 of the Listing Regulations and pursuant to Section 178 of the Act. The
main object of this Committee is to identify persons who are qualified to become directors
and who may be appointed in senior management of your Company, recommend to the Board
their appointment and removal and shall carry out evaluation of every Director's
performance, recommend the remuneration package of both the Executive and the
Non-Executive Directors on the Board and also the remuneration of Senior Management, one
level below the Board. The Committee reviews the remuneration package of the Executive
Director(s), makes appropriate recommendations to the Board and acts in terms of reference
of the Board from time to time.
On the recommendation of the Nomination and Remuneration Committee, the
Board has adopted and framed a Remuneration Policy for the Directors, Key Managerial
Personnel and other Employees pursuant to the provisions of the Act and the Listing
Regulations which is available on the website of your Company which may be accessed at
https://athenagt.com/investors
The remuneration determined for Executive/Non- Executive Directors is
based on the recommendation of the Nomination and Remuneration Committee and approval of
the Board of Directors. The Non-Executive Directors are entitled to sitting fees for
attending meetings of the Board and the Committees. The remuneration paid to Directors,
Key Managerial Personnel and all other employees is in accordance with the Remuneration
Policy of your Company.
Brief terms of Nomination and Remuneration Committee and other matters
provided in Section 178(3) of the Act and Regulation 19 of the Listing Regulations have
been disclosed in the Corporate Governance Report, which forms part of this Report.
b) Familiarization/ Orientation program for Independent Directors:
Formal familiarization programs were conducted about the amendments in
the Companies Act, Rules prescribed thereunder, Listing Regulations and all other
applicable laws to your Company and all the directors were also apprised about the
business activities of the Company.
It is the general practice of your Company to notify the changes in all
the applicable laws to the Board of Directors, from time to time. The objective of these
programs is to familiarize Independent Directors with the business of your Company, the
industry in which your Company operates, business model, challenges etc. through various
means such as interaction with subject matter experts, meetings with business leads and
functional heads on a regular basis
The details of such familiarization programs for Independent Directors
are posted on the website of your Company and web link is https://athenagt.com/investors
40. ANNUAL EVALUATION OF BOARD PERFORMANCE AND PERFORMANCE OF ITS
COMMITTEES AND INDIVIDUAL DIRECTORS
Pursuant to the provisions of the Act and the Listing Regulations, the
Board has carried out the annual performance evaluation of its own performance, the
Directors individually as well as the evaluation of the working of its Audit Committee,
Nomination and Remuneration Committee and all other Committees.
A structured questionnaire was prepared after taking into consideration
the inputs received from the Directors, covering various aspects of the Board's
functioning such as adequacy of the composition of the Board and its Committees, Board
culture, execution and performance of specific duties, obligations and governance.
A separate exercise was carried out to evaluate the performance of
individual Directors including the Chairman of the Board, who were evaluated on parameters
such as level of engagement and contribution, independence of judgment, safeguarding the
interest of your Company and its minority shareholders etc. The performance evaluation of
the Independent Directors was carried out by the entire Board, excluding the Independent
Director being evaluated.
In a separate meeting of Independent Directors, performance of
Non-Independent Directors, the Board as a whole and the Chairman of your Company was
evaluated, taking into account the views of the Executive Director and Non-Executive
Directors who also reviewed the performance of the Secretarial Department. The Nomination
and Remuneration Committee reviewed the performance of individual directors on the basis
of criteria such as, contribution of the individual director to the Board and Committee
meetings, preparedness on the issues to be discussed, meaningful and constructive
contribution and inputs in meetings, etc.
The Directors expressed their satisfaction with the evaluation process.
41. PARTICULARS OF EMPLOYEES AND REMUNERATION
The information required pursuant to Section 197 of the Companies Act,
read with Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel)
Rules, 2014 in respect of employees of your Company is herewith annexed as Annexure IV to
this report.
42. CORPORATE GOVERNANCE
Your Company has been making every endeavor to bring more transparency
in the conduct of its business. As per the requirements of Regulation 34 (3) of the
Listing Regulations, a report on Corporate Governance for the year 2025-26 and a
Certificate from M/s. P S Rao & Associates, Company Secretaries are furnished as Annexure
VII which forms part of this Annual Report.
43. POLICY ON SEXUAL HARASSMENT:
Your Company strongly supports the rights of all its employees to work
in an environment, free from all forms of harassment. Your Company has adopted a Policy on
Prevention, Prohibition and Redressal of Sexual Harassment at workplace as per the
provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and
Redressal) Act, 2013 and the Rules made thereunder. The policy aims to provide protection
to Employees at the workplace and prevent and redress complaints of sexual harassment and
for matters connected or incidental thereto, with the objective of providing a safe
working environment, where Employees feel secure.
Your Company has also constituted an Internal Complaint Committee,
known as Anti Sexual Harassment Committee, to address the concerns and complaints of
sexual harassment and to recommend appropriate action.
(a) Number of complaints of sexual harassment received in the year: Nil
(b) Number of complaints disposed off during the year: Nil
(c) Number of cases pending for more than ninety days: N.A.
44. COMPLIANCE WITH THE PROVISIONS RELATING TO THE MATERNITY BENEFITS
ACT, 1961.
Your Company complies with the provisions of the Maternity Benefit Act,
1961, extending all statutory benefits to eligible women employees, including paid
maternity leave, continuity of salary and service during the leave period, and
post-maternity support such as nursing breaks and flexible return-to-work options, as
applicable. Your company remains committed to fostering an inclusive and supportive work
environment that upholds the rights and welfare of its women employees in accordance with
applicable laws.
45. ENERGY CONSERVATION, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE
EARNINGS AND OUTGO
The information on conservation of energy, technology absorption and
foreign exchange earnings and outgo stipulated under Section 134(3)(m) of the Act read
with Rule 8 of The Companies (Accounts) Rules, 2014, is annexed herewith as Annexure
III to this report.
46. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
There are no significant or material orders passed by the Regulators /
Courts which would impact the going concern status of your Company and its future
operations.
47. DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE
INSOLVENCY AND BANKRUPTCY CODE, 2016 (31 OF 2016) DURING THE YEAR ALONG WITH THEIR STATUS
AS AT THE END OF THE FINANCIAL YEAR:
No application was made or any proceedings were pending under the IBC,
2016 during the year ended on March 31,2026.
48. DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT THE
TIME OF ONE-TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR
FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF:
Not Applicable
49. GREEN INITIATIVE IN CORPORATE GOVERNANCE
The Ministry of Corporate Affairs (MCA) has taken a green initiative in
Corporate Governance by allowing paperless compliances by the Companies and permitted the
service of Annual Reports and documents to the shareholders through electronic mode
subject to certain conditions and your Company continues to send Annual Reports and other
communications in electronic mode to the members who have registered their email addresses
with your Company/RTA.
50. ACKNOWLEDGMENTS
Your Directors take this opportunity to express their sincere
appreciation to the employees, shareholders, customers, bankers and other business
associates for the excellent support and cooperation extended by them.
Your Directors gratefully acknowledge the sustained co- operation and
support provided by the Central and State Governments, Stock Exchange, SEBI, RBI and other
Regulatory Bodies.
|
By Order of the board ATHENA GLOBAL
TECHNOLOGIES LIMITED |
|
|
Sd/- |
Sd/- |
|
M. Satyendra |
M.Sunitha |
| Place: Hyderabad |
Chairman & Managing Director |
Director |
| Date : 14.08.2026 |
(DIN: 01843557) |
(DIN:06741426) |